2025-05-16 - Analysis Report
Okay, here's an analysis of Exxon Mobil Corp (XOM) based on the provided data, presented in English with a focus on key figures and straightforward analysis:

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** XOM
*   **Company:** Exxon Mobil Corp (An integrated oil and gas company.)
*   **XOM Cumulative Return:** 21.39%
*   **VOO Cumulative Return:** 81.82%
*   **Performance Gap:** -60.4%
*   **Relative Performance Gap (Range-Adjusted):** 36.7

**Analysis:** XOM significantly underperformed the S&P 500 (VOO) over the specified period.  The relative performance gap of 36.7 indicates XOM's underperformance is towards the lower end of its historical range compared to VOO.

**Alpha, Beta Analysis**

| Year       | CAGR  | MDD   | Alpha  | Beta  | Cap(B) |
|------------|-------|-------|--------|-------|--------|
| 2015-2017  | 9.0%  | 7.1%  | -21.0% | -0.1  | 256.7  |
| 2016-2018  | -2.0% | 64.6% | -19.0% | -0.1  | 218.0  |
| 2017-2019  | -7.0% | 64.6% | -36.0% | -0.9  | 233.8  |
| 2018-2020  | -41.0% | 64.6% | -67.0% | -0.4  | 149.1  |
| 2019-2021  | 4.0%  | 61.9% | -51.0% | -0.4  | 235.0  |
| 2020-2022  | 68.0% | 72.9% | 62.0%  | -0.2  | 440.3  |
| 2021-2023  | 62.0% | 72.9% | 46.0%  | -0.1  | 412.8  |
| 2022-2024  | 11.0% | 72.9% | -6.0%  | 0.4   | 459.2  |
| 2023-2025  | -36.0% | 72.3% | -66.0% | 0.9   | 464.6  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, showing periods of strong growth (2020-2023) and significant decline (2018-2020, 2023-2025).
*   **MDD:** Relatively high Maximum Drawdown, indicating substantial risk.
*   **Alpha:**  Generally negative, suggesting underperformance relative to its benchmark. Some positive alpha was observed in 2020-2023.
*   **Beta:** Typically close to zero or negative, suggesting low correlation with the overall market. More recently, the beta has risen to around 0.4-0.9.
*   **Cap(B):** Market capitalization has generally increased over time.

**2. Recent Price Action**

*   **Current Price:** 107.87
*   **Last Market Data:** Price: 107.83, Previous Close: 107.49, Change: 0.32
*   **5-Day Moving Average:** 107.004
*   **20-Day Moving Average:** 106.502
*   **60-Day Moving Average:** 109.3837

**Analysis:** The current price is above the 5-day and 20-day moving averages, but below the 60-day moving average. This suggests a potential short-term uptrend, but the price is still below longer-term levels. The positive change from the previous close indicates a slight upward movement in the most recent trading session.

**3. Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.35 (Low Risk)
*   **RSI:** 51.64
*   **PPO:** 0.40
*   **Recent (20-Day) Relative Performance Gap Change:** -4.6 (Short-term decline)
*   **Expected Return:** -34.2% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates low market risk.
*   RSI is around 50, suggesting a neutral market momentum (neither overbought nor oversold).
*   The PPO is slightly positive, indicating a potential upward trend.
*   The negative change in the relative performance gap and the negative Expected Return are concerning, suggesting continued underperformance relative to the S&P 500 in the long term.
*   The price change of 0.32 suggests no significant volatile reaction.

**4. Recent News & Significant Events**

*   **Headlines indicate:** Recent business developments, regulatory changes, market events, and volatility.  Analysts are discussing the company's performance and outlook. Market experts highlight both risks and opportunities.

**Analysis:** The news suggests XOM is facing significant changes and scrutiny. The volatility mentioned is a key factor to consider.

**5. Recent Earnings Analysis**

| Date       | EPS  | Expected EPS |
|------------|------|--------------|
| 2025-05-02 | 1.76 | 1.75         |
| 2025-01-31 | 1.67 | 1.77         |
| 2024-11-01 | 1.92 | 1.88         |
| 2024-08-02 | 2.14 | 2.01         |
| 2024-04-26 | 2.06 | 2.2          |

**Analysis:**  XOM has generally met or exceeded EPS expectations in recent quarters, except for 2025-01-31 and 2024-04-26. This positive earnings performance could be a supportive factor for the stock.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $81.06B  | 22.80%        |
| 2024-12-31 | $81.06B  | 21.28%        |
| 2024-09-30 | $87.79B  | 23.23%        |
| 2024-06-30 | $89.99B  | 22.44%        |
| 2024-03-31 | $80.41B  | 23.51%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-03-31 | $262.72B | 2.94% |
| 2024-12-31 | $263.70B | 2.89% |
| 2024-09-30 | $268.59B | 3.21% |
| 2024-06-30 | $268.40B | 3.44% |
| 2024-03-31 | $205.25B | 4.00% |

**Analysis:**

*   **Revenue:** Revenue has been fluctuating slightly.
*   **Profit Margin:** Profit margins are relatively stable.
*   **Equity:** Equity has generally increased.
*   **ROE:** ROE has fluctuated, recently trending downwards.

**7. Overall Summary**

Exxon Mobil (XOM) has significantly underperformed the S&P 500 (VOO) over the period.  While recent earnings have generally been positive, long-term expected returns remain negative.  The company faces volatility and is subject to regulatory changes and market events. Revenue and profit margins are relatively stable, but ROE has been trending downwards. The low Market Risk Indicator (MRI) is positive.

**Recommendation:** Given the long-term underperformance and negative expected return, a cautious approach is warranted.  Investors should closely monitor news, earnings reports, and industry trends before making any decisions. The short-term uptrend suggested by moving averages requires further confirmation.
